Botanical species · safety record

Balanites aegyptiaca

The EFSA Compendium of Botanicals holds 16 constituent measurements and 1 adverse-effect record for Balanites aegyptiaca. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Balanites aegyptiaca (L.) Delile

16Constituent measurements
1Safety records
8Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Tannins4
  • Saponins3
  • Cardiac glycosides2
  • Anthraquinones1
  • Balanitoside1
  • Coumarins1
  • Hydrocyanic acid1
  • Moupinamide1
  • Oxalates1
  • Trigonelline1

Plant parts

  • Fruit unspecified4
  • Leaves4
  • Aerial part of plants2
  • Bark2
  • Roots and other underground parts2
  • Seed2
  • Live plants1

Preparations

  • Solvent extraction12
  • Fresh2

Effect types

  • Not reported1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BalanitosideFruit unspecifiedColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
MoupinamideBarkSolvent extractionHPLC with standard detection methodsResolve DOI
TrigonellineFruit unspecifiedSolvent extractionLC-MSResolve DOI
AnthraquinonesLeavesSolvent extraction< 10 Milligram/kilogramPhytochemical screeningNo resolvable identifier
Cardiac glycosidesLeavesSolvent extraction≤ 50 Milligram/kilogramPhytochemical screeningNo resolvable identifier
Cardiac glycosidesLeavesSolvent extraction≥ 10 Milligram/kilogramPhytochemical screeningNo resolvable identifier
CoumarinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Hydrocyanic acidSeed3.5 Milligram/100 gramTraditional analytical techniques (wet chemical tests)No resolvable identifier
OxalatesFruit unspecifiedFresh14.5 PercentTraditional analytical techniques (wet chemical tests)No resolvable identifier
SaponinsFruit unspecifiedFresh16 PercentTraditional analytical techniques (wet chemical tests)No resolvable identifier
SaponinsLive plantsSolvent extraction> 100 Milligram/kilogramPhytochemical screeningNo resolvable identifier
SaponinsSeed7 PercentTraditional analytical techniques (wet chemical tests)No resolvable identifier
TanninsRoots and other underground partsSolvent extraction≤ 100 Milligram/kilogramPhytochemical screeningNo resolvable identifier
TanninsRoots and other underground partsSolvent extraction≥ 50 Milligram/kilogramPhytochemical screeningNo resolvable identifier
TanninsAerial part of plantsSolvent extraction≤ 50 Milligram/kilogramPhytochemical screeningNo resolvable identifier
TanninsAerial part of plantsSolvent extraction≥ 10 Milligram/kilogramPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not reportedBarkSolvent extractionNile tilapiaCase reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ojo, OO., Nadra, MS., Tella, IO. Protection of rats by extracts of some common Nigerian trees against acetaminophen-induced hepatotoxicity. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2006, vol. 5, no. 9, p. 755-760.
  2. Sarker, S. D., Bartholomew, B., Nash, R. J. Alkaloids from Balanites aegyptiaca. Fitoterapia, 2000, vol. 71, no. 3, p. 328-330. DOI
  3. Farag, M.A., Porzel, A., Wessjohann, L.A. Unraveling the active hypoglycemic agent trigonelline in Balanites aegyptiaca date fruit using metabolite fingerprinting by NMR. Journal of pharmaceutical and biomedical analysis, 2015, vol. 115, p. 383-387. DOI
  4. Umaru, H. A., Adamu, R., Dahiru, D., Nadro, M. S. Levels of antinutritional factors in some wild edible fruits of Northern Nigeria. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2007, vol. 6, no. 16, p. 1935-1938.
  5. Nkafamiya, I. I., Modibbo, U. U., Manji, A. J., Haggai, D. Nutrient content of seeds of some wild plants. African journal of biotechnology, 2007, vol. 6, no. 14, p. 1665-1669.
  6. Kumawat, B.K., Gupta, M., Chand, T., Singh, Y. Prelimenary phytochemical investigation on leaves of Balanites aegyptiaca (L.) Delile. Research journal of pharmaceutical, biological and chemical sciences, 2012, vol. 3, no. 2, p. 762-768.
  7. Ufodike, E. B. C., Omoregie, E. Acute toxicity of water extracts of barks of Balanites aegyptiaca and Kigelia africana to Oreochromis niloticus (L.). Aquaculture and Fisheries Management, 1994, vol. 25, no. 9, p. 873-879. DOI
  8. HOSNY, M., KHALIFA, T., CALIS, I., WRIGHT, AD., STICHER, O. BALANITOSIDE, A FUROSTANOL GLYCOSIDE, AND 6-METHYL-DIOSGENIN FROM BALANITES-AEGYPTIACA . Phytochemistry, 1992, vol. 31, no. 10, p. 3565-3569. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue